Today: 14 March 2026
Subscribe
Browse Category

Stock Market 11 December 2025

Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio shares climbed to $154 on December 11, 2025, up over 130% year-to-date, after announcing positive Phase 3 results for tinlarebant in Stargardt disease. The company’s market value reached $5–6 billion. The DRAGON trial showed tinlarebant cut lesion growth by 36% versus placebo in adolescents with STGD1. Wall Street analysts project further upside for the stock.
11 December 2025
·
Wayfair (W) Stock Nears $100 as Hedge Funds Buy and Jefferies Turns Cautious – December 11, 2025 Outlook & Forecast

Wayfair (W) Stock Nears $100 as Hedge Funds Buy and Jefferies Turns Cautious – December 11, 2025 Outlook & Forecast

Wayfair shares rose about 7% Thursday to near $100, following a volatile year that saw the stock rally over 100% year to date but fall 17% in the past month. The stock remains nearly 19% below its November high. Hedge funds, including Mane Global Capital, disclosed new stakes, while short interest hovers near 15%. Insiders have been selling as analysts remain split on the outlook.
11 December 2025
··
Wells Fargo Stock (WFC) Near Record Highs: Latest News, AI Job Cuts, Buybacks and 2026 Forecast

Wells Fargo Stock (WFC) Near Record Highs: Latest News, AI Job Cuts, Buybacks and 2026 Forecast

Wells Fargo stock closed at $90.68 on December 10, 2025, near its 52-week high, after the Federal Reserve lifted its asset cap in June and the bank announced a $40 billion share buyback. Shares have gained over 26% year-to-date, outpacing peers. Technical models now rate WFC a “Strong Buy” for the next three months. Regulatory scrutiny and legal settlements remain ongoing.
11 December 2025
··
Upwork (UPWK) Stock Hits Fresh 52‑Week High: AI Partnerships, Index Inclusion and Q3 Earnings Rewire the 2026 Outlook

Upwork (UPWK) Stock Hits Fresh 52‑Week High: AI Partnerships, Index Inclusion and Q3 Earnings Rewire the 2026 Outlook

Upwork shares hit a new 52-week high of $21.39 on December 11, 2025, lifting its market cap to about $2.46 billion. The stock is up nearly 90% from its yearly low, driven by record Q3 results, new AI partnerships, and entry into the S&P SmallCap 600. Insider selling and high short interest remain. Upwork now posts positive GAAP earnings and a gross margin near 78%.
11 December 2025
····
Marvell Technology (MRVL) Stock: AI Infrastructure Star Faces Fresh Amazon and Microsoft Risks After November Rally

Marvell Technology (MRVL) Stock: AI Infrastructure Star Faces Fresh Amazon and Microsoft Risks After November Rally

Marvell Technology shares rose about 17% to $90–91 as of December 11, 2025, after reporting record earnings and announcing a multi-billion-dollar AI acquisition. The stock had closed at $77.45 on November 21, before spiking near $100 and then retreating on concerns over business with Amazon and Microsoft. Institutional investors increased holdings, while insiders bought shares around $78. Trading volume and volatility surged.
11 December 2025
···
Coca-Cola (KO) Stock Outlook December 2025: New CEO, Dividend Power and Analyst Forecasts

Coca-Cola (KO) Stock Outlook December 2025: New CEO, Dividend Power and Analyst Forecasts

Coca-Cola shares traded around $69–70 intraday on December 11, 2025, down from late-November highs above $73 but well above the 52-week low. The board named Henrique Braun as CEO effective March 31, 2026, with James Quincey moving to Executive Chairman. KO delivered an estimated 11.9% one-year return, lagging the S&P 500 but outperforming its industry.
11 December 2025
···
Lumentum Holdings (LITE) Stock Soars Above $360 on AI Optics Boom: Price Targets, Valuation and 2026–2028 Forecasts After the November Rally

Lumentum Holdings (LITE) Stock Soars Above $360 on AI Optics Boom: Price Targets, Valuation and 2026–2028 Forecasts After the November Rally

Lumentum shares surged to $366 on December 11, 2025, after hitting a record $300.20 on November 26. The stock is up nearly 290% year-to-date, driven by soaring demand for AI datacenter optics and cloud networking. Fiscal 2025 revenue rose 21% to $1.65 billion, and the company swung to a $25.9 million profit from a $546.5 million loss. Over 60% of recent revenue is tied to AI and cloud infrastructure.
11 December 2025
·
Brinker International (EAT) Stock: Fresh News, Analyst Forecasts and Turnaround Outlook as of December 11, 2025

Brinker International (EAT) Stock: Fresh News, Analyst Forecasts and Turnaround Outlook as of December 11, 2025

Brinker International shares rose 7% to $146 intraday on December 11, 2025, after outperforming short-term trading models and drawing institutional interest. The stock remains 24% below its 52-week high and 46% above its low. Chili’s same-store sales have grown by high teens to low 20% in recent quarters, driving improved margins and over $500 million in debt reduction.
11 December 2025
··
Home Depot (HD) Stock Outlook: Q3 2025 Earnings, 2026 Guidance and Wall Street Forecasts After the November Slide

Home Depot (HD) Stock Outlook: Q3 2025 Earnings, 2026 Guidance and Wall Street Forecasts After the November Slide

Home Depot shares traded near $361 on December 11, about 16% below their 52-week high of $428. The stock is down roughly 10% year-to-date, lagging the S&P 500’s 16% gain. Q3 net sales rose 2.8% to $41.4 billion, but net earnings were flat and EPS slipped. Management cited weak housing and consumer demand as ongoing challenges.
11 December 2025
···
Lemonade (LMND) Stock Soars to 52-Week High on Tesla Integration and Q3 2025 Beat: Is the Rally Sustainable?

Lemonade (LMND) Stock Soars to 52-Week High on Tesla Integration and Q3 2025 Beat: Is the Rally Sustainable?

Lemonade shares traded near $82 on December 11, 2025, after hitting a 52-week high above $84.50, up from a low near $24. The company’s market cap has more than doubled to about $6 billion in the past year. Lemonade’s price-to-sales ratio stands near 9x, far above traditional insurers. Q3 revenue rose 42% year-over-year to about $195 million.
11 December 2025
····
Broadcom (AVGO) Stock on December 11, 2025: AI Giant Faces Earnings Test, VMware Scrutiny and Sky‑High Expectations

Broadcom (AVGO) Stock on December 11, 2025: AI Giant Faces Earnings Test, VMware Scrutiny and Sky‑High Expectations

Broadcom shares traded near record highs at $399 on December 11, 2025, ahead of its Q4 earnings report. The company expects Q4 revenue of $17.4 billion, up 24% year-over-year, with AI chip sales driving growth. Options markets are pricing in a possible 6% swing after results. Broadcom faces new regulatory scrutiny in Europe.
11 December 2025
·····
Rocket Lab (RKLB) Stock in 2025: Q3 Earnings, Neutron Milestones and Analyst Forecasts After the November 21 Sell‑Off

Rocket Lab (RKLB) Stock in 2025: Q3 Earnings, Neutron Milestones and Analyst Forecasts After the November 21 Sell‑Off

Rocket Lab stock plunged 40% into November 21, 2025, then rebounded as new Neutron rocket milestones and government funding were announced. Q3 revenue hit a record $155 million, up 48% year-over-year, while net loss narrowed to $18 million. The company’s valuation remains steep, with a price-to-sales ratio near 38x and ongoing losses. Analyst forecasts expect continued high growth but warn of risks.
11 December 2025
····
Rhythm Pharmaceuticals (RYTM) Hits Record High on Rare-Disease Breakthrough: Latest News, Stock Forecast and Analyst Outlook

Rhythm Pharmaceuticals (RYTM) Hits Record High on Rare-Disease Breakthrough: Latest News, Stock Forecast and Analyst Outlook

Rhythm Pharmaceuticals shares jumped over 15% to a record high near $121 on December 11 after reporting positive interim Phase 2 data for setmelanotide in Prader-Willi syndrome. Six of eight patients showed BMI reductions at three months, and most saw declines in hunger scores. The company plans a Phase 3 trial pending Phase 2 completion. RYTM stock is up around 80–90% year-to-date.
11 December 2025
·
Carvana Stock (CVNA) Rockets Higher: What the 12‑Day Rally, S&P 500 Inclusion and 2025 Forecasts Mean for Investors

Carvana Stock (CVNA) Rockets Higher: What the 12‑Day Rally, S&P 500 Inclusion and 2025 Forecasts Mean for Investors

Carvana shares have surged about 50% since November 21, 2025, hitting record highs near $471 after a 12-session rally. The stock will join the S&P 500 on December 22, prompting heavy index fund buying. Carvana reported strong Q3 results, but its valuation now exceeds 50 times forward earnings, drawing skepticism from some analysts.
11 December 2025
··
CoreWeave Stock in December 2025: Debt Jitters, AI Cloud Growth and What Comes Next for CRWV

CoreWeave Stock in December 2025: Debt Jitters, AI Cloud Growth and What Comes Next for CRWV

CoreWeave (Nasdaq: CRWV) traded at $82–83 midday December 11, down from a 2025 high near $187 but above its $40 March IPO. Q3 revenue rose 133% to $1.36 billion, but the company posted a net loss of $110 million, citing $310 million in interest expense. CoreWeave cut 2025 revenue guidance in November after data-center delays, triggering a sharp sell-off. Market cap stands in the mid-$40 billion range.
11 December 2025
··
Credo Technology Group (CRDO) Stock: 7% Pullback, Fresh Institutional Buying and New Price Targets on December 11, 2025

Credo Technology Group (CRDO) Stock: 7% Pullback, Fresh Institutional Buying and New Price Targets on December 11, 2025

Credo Technology Group shares fell 7.5% Wednesday to $157.57, their steepest drop since IPO, and traded near $154.50 Thursday. Q2 FY2026 revenue jumped 272% on AI data-center demand, with EPS turning positive and cash flow up fourfold. Institutional activity is mixed, with new positions from Rokos and AXA and trimming by Federated Hermes. Analysts maintain strong buy ratings despite valuation concerns.
11 December 2025
··
Applied Optoelectronics (AAOI) Surges on 800G Hyperscale Order as Analysts Hike Price Targets to $50

Applied Optoelectronics (AAOI) Surges on 800G Hyperscale Order as Analysts Hike Price Targets to $50

Applied Optoelectronics secured its first volume order for 800G data center transceivers from a major hyperscale customer, expected to add $4–8 million to Q4 2025 revenue. Shares jumped to around $34.98 after the news, as analysts raised price targets to as high as $50. The company’s market cap stands near $2.4 billion. Trading volume spiked following the announcement.
11 December 2025
··
Johnson & Johnson (JNJ) Stock Near Record Highs: Latest News, Legal Risks and 2026 Outlook for Investors

Johnson & Johnson (JNJ) Stock Near Record Highs: Latest News, Legal Risks and 2026 Outlook for Investors

Johnson & Johnson stock hit a 52-week high of about $208 on December 11, 2025, lifting its market cap above $500 billion after a rally that outpaced the S&P 500. The surge followed strong oncology trial results, new drug approvals, and optimism about offsetting Stelara sales declines. Legal risks and pricing pressures remain. JNJ’s dividend yield stands near 2.5%.
11 December 2025
·
T-Mobile US (TMUS) Stock on December 11, 2025: Dividend Growth, Analyst Targets and 5G Scrutiny

T-Mobile US (TMUS) Stock on December 11, 2025: Dividend Growth, Analyst Targets and 5G Scrutiny

T-Mobile US shares traded near $196 on December 11, 2025, close to 12-month lows and down about 9% year-to-date. The company raised its quarterly dividend by 16% to $1.02 per share in September and faces increased regulatory and competitive pressure as it invests in 5G. T-Mobile’s Hometown Grants program has awarded $20 million to 450 U.S. communities.
11 December 2025
···
1 … 966 967 968 969 970 … 1,350

Stock Market Today

  • Dave (DAVE) Shares Surge 146% in One Year: Overvalued or Undervalued?
    March 14, 2026, 11:32 AM EDT. Dave's stock has soared 145.7% over the past year, closing recently at $212.02. Despite strong multi-year gains, a key valuation check marks the stock as 381.6% overvalued, based on an Excess Returns analysis that compares earnings to required shareholder returns. The company shows a 20.26% average return on equity, but intrinsic value estimates stand at $44.02 per share versus current prices. Other valuation models, including price-to-earnings (P/E) ratios, are being assessed to gauge market expectations and risk. Investors are balancing Dave's robust performance against these metrics, navigating whether the rally has priced in future growth or leaves room for further gains.
Go toTop